Skip Navigation

Profile

Roy E. Strowd, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

81 Ratings
4 Comments
 

Roy E. Strowd, M.D.

Assistant Professor,
Ctr for Vaccines at Extremes

Contact Information

Returning Patient Appointments: 336-716-4101
Department: 336-716-4101

Insurance Accepted »

Education & Training

  • M.D., WFU School of Medicine, 2009
  • Residency, Neurology, NC Baptist Hospital, 2013
  • Fellowship, Neurology, Johns Hopkins Hosp, 2015

Board Certifications

  • American Board of Psychiatry and Neurology, Neurology

NPI Number

  • 1982830998
Roy E. Strowd, M.D.

Doctor Rating

4.7 out of 5

81 Ratings
4 Comments
 

Roy E. Strowd, M.D.

Assistant Professor, Neurology
Ctr for Vaccines at Extremes
Hematology & Oncology

Research Interests

Central Nervous System Neoplasms; Brain Neoplasms; Neurology; Students, Medical; Education, Medical
More »

Contact Information

Department: 336-716-4101

Recent Publications

Education research: difficult conversations in neurology: lessons learned from medical students. Lemmon ME, Gamaldo C, Salas RME, Saxena A, Cruz TE, Boss RD, Strowd RE.. Neurology. 2018;90(2):93-97.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide. McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD.. Am J Clin Oncol. 2017;():.

Head drop after botox: electrodiagnostic evaluation of iatrogenic botulinum toxicity. Szuch E, Caress JB, Paudyal B, Brashear A, Cartwright MS, Strowd RE III.. Clin Neurol Neurosurg. 2017;156():1-3.

Meeting update-Society for Neuro-Oncology 2016 annual meeting. Strowd RE, Kim AH.. Neuro Oncol. 2017;19(2):150-152.

Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. Wang EC, Huang AJ, Huang KE, McTyre ER, Lo HW, Watabe K, Metheny-Barlow L, Laxton AW, Tatter SB, Strowd RE, Chan MD, Page BR.. J Clin Neurosci. 2017;43():6-10.

Multi-agent vs. single-agent intra-ventricular chemotherapy for patients with neuroplastic meningitis: evidence supporting a new paradigm [abstract]. Eby R, Zacharia B, Cream L, Black D, Aregawi D, Mrowczynski O, Strowd R, Grossman S, Claxton, D, Glantz M.. Neuro Oncol. 2017;19(Suppl 3):103.

In situ detection of hypoxia inducible factor 2 alpha in malignant gliomas [abstract]. Renfrow JJ, Strowd RE, Huang Y, Herpai D, Mott RT, Wong T, Lesser GJ, Debinski W.. Neuro Oncol. 2017;19(Suppl 3):57.

Surgical considerations in the optimal management of patients with malignant brain tumors. Renfrow JJ, Strowd RE, Laxton AW, Tatter SB, Geer CP, Lesser GJ.. Curr Treat Options Oncol. 2017;18(8):46.

Late post-treatment radiographic changes 3 years following chemoradiation for glioma: the importance of histopathology. Galante JR, Rodriguez F, Grossman SA, Strowd RE.. CNS Oncol. 2017;():.

Neurological complications of immunotherapies-beware of the checkpoint ahead [editorial]. Strowd RE III.. JAMA Neurol. 2017;74(10):1176-1177.

Educational priorities of students in the entrustable professional activity era. Strowd RE, McBride A, Goforth J, Cristiano J, Hartman N, Waters G, Beardsley J, Johnson JE, Askew K.. Clin Teach. 2017;():.

Meeting update-World Federation of Neuro-Oncology Societies (WFNOS) Meeting 2017. Renfrow JJ, Weller M, Strowd RE.. Neuro Oncol. 2017;19(11):1457-1459.

Safety and efficacy of intraventricular biologic agents as part of a multi-agent intraventricular treatment regimen for patients with neoplastic meningitis [abstract]. Bernstein A, Mrowczynski O, Strowd RE, Cream L, Ruda R, Jeyapalan S, Eby R, Black D, Patrikidou A, Hofer S, Ferreri A, Glantz M.. Neuro Oncol. 2017;19(Suppl 6):47.

Feasibility of proton MRS for assessing cerebral metabolic activity of an Atkins-based diet in patients with glioma [abstract]. Schreck KC, Berrington A, Barron BM, Blair L, Hartman A, Kossoff E, Easter L, Whitlow C, Hsu FC, Cervenka MC, Blakeley JO, Barker PB, Strowd RE.. Neuro Oncol. 2017;19(Suppl 6):163.

Re-irradiation for recurrent high grade glioma (HGG): evaluation of tolerable radiation dose and role of chemotherapy [abstract]. Kummerlowe M, Shen C, Redmond K, Martinez JC, Usama SM, Strowd RE, Kleinberg L.. Neuro Oncol. 2017;19(Suppl 6):224.

Effect of ketogenic diets on leukocyte counts in patients with epilepsy. Schreck KC, Lwin M, Strowd RE, Henry-Barron BJ, Blakeley JO, Cervenka MC.. Nutr Neurosci. 2017;():.

Hippocampal dose volume histogram predicts Hopkins Verbal Learning Test scores after brain irradiation. Okoukoni C, McTyre ER, Ayala Peacock DN, Peiffer AM, Strowd R, Cramer C, Hinson WH, Rapp S, Metheny-Barlow L, Shaw EG, Chan MD.. Adv Radiat Oncol. 2017;2(4):624-629.

Association between subthalamic nucleus deep brain stimulation and weight gain: results of a case-control study. Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS.. Clin Neurol Neurosurg. 2016;140():38-42.

Cutaneous manifestations in neuro-oncology: clinically relevant tumor and treatment associated dermatologic findings. Strowd RE, Strowd LC, Blakeley JO.. Semin Oncol. 2016;43(3):401-407.

The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide. Strowd RE, Abuali I, Ye X, Lu Y, Grossman SA.. J Neurooncol. 2016;127(1):165-171.

Flipping the switch: the feasibility of a 'think aloud' flipped-classroom approach to clinical reasoning instruction. Strowd RE, Gamaldo CE, Kwan AB, Cruz TE, Salas RME.. J Contemp Med Educ. 2016;2(2):40-47.

Neurology clerkship goals and their effect on learning and satisfaction. Strowd RE, Salas RM, Cruz TE, Gamaldo CE.. Neurology. 2016;86(7):684-691.

End-of-life care for glioblastoma multiforme patients at an academic institution [abstract]. Kuchinad K, Strowd RE, Evans A, Knight L, Riley WA, Smith TJ.. J Clin Oncol. 2016;34(7 Suppl):202.

Hippocampal dosimetry predicts for cancer-related cognitive impairment in patients treated with cranial radiation therapy: dosimetric results of a prospective clinical trial [abstract]. Okoukoni C, McTyre E, Peiffer AM, Hinson W, Strowd RE, Rapp S, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S90-S91.

Reirradiation for recurrent high-grade glioma: evaluation of dose escalation and concurrent chemotherapy [abstract]. Shen C, Redmond KJ, Martinez-Gutierrez JC, Kummerlowe M, Usama SM, Strowd RE, Kleinberg LR.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E136.

Genomic predictors of imaging response and survival in glioblastoma [abstract]. Soike M, McTyre E, Holmes JA, Paulsson AK, Miller L, Lesser GJ, Strowd RE, Johnson A, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E121-E122.

Applying lean thinking: the assessment of professional conduct of medical students. Gamaldo CE, Gamaldo AA, Strowd RE, Hou L, Kalloo A, Sanchez MA, Salas RE.. Creat Educ. 2016;7():861-869.

Speaking the same language: cross-sectional assessment of perceived contributors to professionalism across generations. Strowd RE, Saylor D, Salas RM, Thorpe R, Cruz TE, Gamaldo CE.. Neurol Clin Pract. 2016;6(3):230-240.

Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: hormonal and radiographic response. Strowd RE, Salvatori R, Laterra JJ.. J Oncol Pharm Pract. 2016;22(3):517-522.

Lumbosacral plexus involvement as the first site of metastatic recurrence in a patient with CTNNB1-mutant prostate cancer. Markowski MC, Wobker SE, Strowd RE III, Antonarakis ES.. Clin Genitourin Cancer. 2016;14(4):e417-e422.

The Neurology Resident & Fellow section: year in review [editorial]. Millichap JJ, Strowd RE.. Neurology. 2016;87(17):1748-1749.

Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Randolph DM II, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, Strowd R, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Clin Neurol Neurosurg. 2016;151():73-78.

Right brain: breaking bad news: communication education for neurology trainees. Lemmon ME, Strowd RE III.. Neurology. 2016;87(24):e285-e287.

Inter-interpreter consistency in reviewing histopathology from patients with glioblastoma and radiographic progression following standard radiation and temozolomide [abstract]. Piotrowski AF, Ye XB, Lu Y, Strowd R, Seopaul S, Rodriguez F, Grossman SA, Burger P, Holdhoff M.. Neuro Oncol. 2016;18(Suppl 6):116.

Upfront chemoradiotherapy in grade 2 low grade glioma, a single institution experience [abstract]. Wicks RT, Bandarage D, Mott RT, Strowd RE, Laxton AW, Tatter SB, Chan MD, Lesser GJ.. Neuro Oncol. 2016;18(Suppl 6):14.

Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G.. J Clin Oncol. 2015;33(15 Suppl):e20669.

Dynamic glucose-enhanced (DGE) MRI: translation to human scanning and first results in glioma patients. Xu X, Yadav NN, Knutsson L, Hua J, Kalyani R, Hall E, Laterra J, Blakeley J, Strowd R, Pomper M, Barker P, Chan K, Liu G, McMahon MT, Stevens RD, van Zijl PC.. Tomography. 2015;1(2):105-114.

A pilot study of influenza vaccine immunogenicity in patients with malignant central nervous system (CNS) tumors [abstract]. Strowd RE, Swett K, Harmon M, Pop-Vicas A, Chan M, Tatter SB, Ellis TL [deceased], Blevins M, High K, Lesser GJ.. Neuro Oncol. 2012;14(Suppl 6):154.

The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies. Strowd RE III, Knovich MA, Lesser GJ.. Curr Treat Options Oncol. 2012;13(4):451-464.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Neurology

Roy E. Strowd, M.D.

Roy E. Strowd, M.D.

Assistant Professor, Neurology
Ctr for Vaccines at Extremes
Hematology & Oncology

Doctor Rating

4.7 out of 5

Roy E. Strowd, M.D.81 Ratings
4 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
3.7



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

11/27/2017

Good experience.

8/15/2017

*Dr. Strowd, listened to my health concerns - took time to show xrays of issues in my body - ordered more detail MRI's for confirmation of issues.

3/1/2017

*Dr. Strowd is a very caring doctor, and he explains everything to me.

2/19/2017

great doc.. easy to understand...doesnt talk 'above your head'

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.